About Us Strategy & Mission Our Values Our People Our Board Our Collaborations Contact Our Programmes Overview Pipeline C. difficile Infection Enterobacteriaceae ESKAPE Programme Clinical Trials Stewardship Compassionate Use Our Science Discuva Platform Publications Investors Investor Centre Press Releases Financial Reports & Filings Email Alerts Events & Presentations Share Price Data Analyst Coverage Corporate Governance Shareholder Meetings Careers
Press Releases Our latest press releases are available to read in this section Press Releases Date Range Explore Search Press Releases / 23 Nov 2020 Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer Press Releases / 16 Nov 2020 Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020 Press Releases / 06 Nov 2020 Summit Announces Closing of Private Placement of $50 Million Press Releases / 05 Oct 2020 Summit Announces Agreement For a Fundraising of approximately $50 Million Press Releases / 29 Sep 2020 Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2020 Press Releases / 18 Sep 2020 Summit Announces Effectiveness of Scheme of Arrangement and Completion of Redomiciliation to Delaware, USA Press Releases / 17 Sep 2020 Summit Therapeutics Announces U.K. Court Approval of Scheme; Expects to Complete Redomiciliation to Delaware, USA as of September 18, 2020 Press Releases / 19 Aug 2020 Summit Announces Results of Court Meeting and General Meeting Press Releases / 16 Jul 2020 Summit Announces Intention to Redomicile its Holding Company to the United States Press Releases / 13 Jul 2020 Publication of Phase 2 Clinical Analyses of Gut Microbiome Health Press Releases / 08 Jun 2020 Summit Appoints Michael Donaldson as Chief Financial Officer Press Releases / 02 Jun 2020 Financial Results and Operational Progress for the First Quarter and Three Months Ended March 31, 2020 1 2 … 27 28 >>
Press Releases / 23 Nov 2020 Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer Press Releases / 16 Nov 2020 Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020 Press Releases / 06 Nov 2020 Summit Announces Closing of Private Placement of $50 Million Press Releases / 05 Oct 2020 Summit Announces Agreement For a Fundraising of approximately $50 Million Press Releases / 29 Sep 2020 Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2020 Press Releases / 18 Sep 2020 Summit Announces Effectiveness of Scheme of Arrangement and Completion of Redomiciliation to Delaware, USA Press Releases / 17 Sep 2020 Summit Therapeutics Announces U.K. Court Approval of Scheme; Expects to Complete Redomiciliation to Delaware, USA as of September 18, 2020 Press Releases / 19 Aug 2020 Summit Announces Results of Court Meeting and General Meeting Press Releases / 16 Jul 2020 Summit Announces Intention to Redomicile its Holding Company to the United States Press Releases / 13 Jul 2020 Publication of Phase 2 Clinical Analyses of Gut Microbiome Health Press Releases / 08 Jun 2020 Summit Appoints Michael Donaldson as Chief Financial Officer Press Releases / 02 Jun 2020 Financial Results and Operational Progress for the First Quarter and Three Months Ended March 31, 2020
Press Releases / 23 Nov 2020 Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating Officer
Press Releases / 16 Nov 2020 Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020
Press Releases / 05 Oct 2020 Summit Announces Agreement For a Fundraising of approximately $50 Million
Press Releases / 29 Sep 2020 Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2020
Press Releases / 18 Sep 2020 Summit Announces Effectiveness of Scheme of Arrangement and Completion of Redomiciliation to Delaware, USA
Press Releases / 17 Sep 2020 Summit Therapeutics Announces U.K. Court Approval of Scheme; Expects to Complete Redomiciliation to Delaware, USA as of September 18, 2020
Press Releases / 16 Jul 2020 Summit Announces Intention to Redomicile its Holding Company to the United States
Press Releases / 02 Jun 2020 Financial Results and Operational Progress for the First Quarter and Three Months Ended March 31, 2020
